EVH Stock Overview
Through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Evolent Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$25.63 |
| 52 Week High | US$35.00 |
| 52 Week Low | US$17.98 |
| Beta | 1.56 |
| 11 Month Change | -15.99% |
| 3 Month Change | 34.12% |
| 1 Year Change | -9.50% |
| 33 Year Change | -22.66% |
| 5 Year Change | 267.72% |
| Change since IPO | 35.90% |
Recent News & Updates
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet
Sep 19
Evolent Health: Let The Bidding Begin
Aug 23Recent updates
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet
Sep 19Evolent Health: Let The Bidding Begin
Aug 23Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk
Jul 29Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Jul 01Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)
May 22These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well
May 05Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares
Apr 08Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital
Mar 12Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)
Dec 21Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
Nov 30A First Evaluation On Evolent Health
Oct 04Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital
Sep 01An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued
Aug 04Evolent Health: Business Economics Still Appealing, Reiterate Buy
Jul 19Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely
Jun 14Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued
May 02Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue
Apr 17Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M
Feb 22Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
Feb 15Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?
Feb 01Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger
Jan 14Evolent spikes as Humana partnership expands
Jan 12Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?
Dec 27Evolent Health offered $23.5M class action securities settlement
Sep 19Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Sep 18Evolent Health: Improving Financials, But There's More
Aug 31Shareholder Returns
| EVH | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -5.2% | -3.3% | -0.7% |
| 1Y | -9.5% | -5.0% | 30.3% |
Return vs Industry: EVH underperformed the US Healthcare Services industry which returned -5% over the past year.
Return vs Market: EVH underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| EVH volatility | |
|---|---|
| EVH Average Weekly Movement | 11.0% |
| Healthcare Services Industry Average Movement | 9.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: EVH's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: EVH's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 4,700 | Seth Blackley | www.evolent.com |
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
Evolent Health, Inc. Fundamentals Summary
| EVH fundamental statistics | |
|---|---|
| Market cap | US$2.97b |
| Earnings (TTM) | -US$106.20m |
| Revenue (TTM) | US$2.35b |
1.2x
P/S Ratio-27.7x
P/E RatioIs EVH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EVH income statement (TTM) | |
|---|---|
| Revenue | US$2.35b |
| Cost of Revenue | US$1.92b |
| Gross Profit | US$437.01m |
| Other Expenses | US$543.21m |
| Earnings | -US$106.20m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.93 |
| Gross Margin | 18.57% |
| Net Profit Margin | -4.51% |
| Debt/Equity Ratio | 48.4% |
How did EVH perform over the long term?
See historical performance and comparison